Kansas Presenters at BIO 2006

All events will take place at the McCormick Place Convention Center unless noted otherwise. The McCormick Place Convention Center is located at 2301 South Lake Shore Drive, Chicago, IL.

OUR REGION: MAKING A DIFFERENCE AT BIO 2006

Innovative Solutions for Translational Research
Sunday, April 9, 2006
11:15 a.m. - 6:30 p.m.
Hyatt Regency Chicago

Sponsored by the Ewing Marion Kauffman Foundation Innovative Solutions for Translational Research is a half-day forum featuring the most innovative and successful solutions to promoting translational research and commercialization.

Lesa Mitchell, Kauffman Foundation Vice President for Advancing Innovation, will moderate the Entrepreneurial Philanthropy to Advance Innovation session.

Lesa Mitchell is responsible for leading the Kauffman Foundation’s initiatives to advance innovations. She has been responsible for the Foundation’s frontier work in understanding the policy levers that influence the advancement of innovation from universities into the commercial market. Prior to joining Kauffman, Mitchell’s professional background included consulting for global pharmaceutical clients such as Takeda and Eli Lilly. She spent 20 years of her career in global executive roles at Aventis and Quintiles. She has a bachelor’s degree from the University of Kansas and volunteers time on various regional boards.

Baiju Shah, BioEnterprise President & CEO, will speak on the External Single and Multi-University Models panel. The Kansas Bioscience Authority has engaged BioEnterprise, Cleveland 's bioscience business development organization, to advise on the development of the organization's business model. Shah has been meeting with Kansas executives and board members since May 2005.

Baiju Shah and BioEnterprise provides management advice, business development and access to capital to privately held medical device, biopharmaceutical and health care services ventures. The BioEnterprise Initiative has helped create, recruit, or accelerate more than 45 companies that have collectively attracted more than $200 million in new funding. Prior to BioEnterprise, Shah was with McKinsey & Company, where he played a leading role in the Growth and Business Building practice and helped develop two new service lines: developing corporate new venture units and monetizing intellectual property. Shah received a J.D. from Harvard Law School and his B.A. from Yale University.

Open to all full and session-only conference registrants.


Biorenewables: Sustainable Growth Opportunities for the Chemical Industry
Tuesday, April 11, 2006
11 a.m. – 12:30 p.m.
McCormick Place Convention Center, Room 401A

Jim Millis, Cargill Technical Director of Industrial Bioproducts and KansasBio Board Member, will speak during the Biorenewables: Sustainable Growth Opportunities for the Chemical Industry session at BIO 2006 in Chicago.

Jim Millis is the Technical Director for the Industrial Bioproducts business of Cargill. He has worked in several technical and management roles at Novozymes, Bio-Technical Resources and Codexis. Millis is a sought-after speaker, and in January, he spoke at the international BIO industrial biomass meeting in Hawaii. He received a B.S. from Cornell and a M.S. from the University of Pittsburg, both in chemical engineering.

Bioethanol: From Fueling Cars to Driving the Biorefining Revolution
Tuesday, April 11, 2006
2 – 3:30 p.m.
McCormick Place Convention Center, Room 401A

Dr. Scott Kohl, ICM Lab Manager, will speak during the Bioethanol: From Fueling Cars to Driving the Biorefining Revolution breakout session at BIO 2006 in Chicago.

ICM was founded in 1995 in Colwich, Kan., with the vision of making ethanol a viable, readily available, domestic alternative to imported petroleum, ICM continually adds to our array of services, striving to improve our already excellent yields and efficiencies. Dr. Scott Kohl grew up on a farm in rural South Dakota and went on to receive his doctorate in Chemistry at South Dakota State University. With his strong farming upbringing, contributing to the success of the agricultural economy is never far from his mind. In addition to his work at ICM, Dr. Kohl writes a column for Ethanol Today magazine.

Open to all full and session-only conference registrants.

BIO 2006 Business Forum

CyDex, Inc.
Dr. John Siebert, Chairman & CEO and KansasBio Board Member
Tuesday, April 11, 2006
4:30 p.m.
McCormick Place South, Level 3 Exhibit Hall A – Room D

Dr. Siebert has focused CyDex on the development of products using CyDex’s innovative, enabling, drug delivery technology. He has reorganized and redirected the company and completed a Series B financing. Prior to joining CyDex, Dr. Siebert was President and Chief Executive Officer of CIMA LABS. Prior to joining CIMA LABS, Dr. Siebert had served in scientific, quality assurance and product development roles with G. D. Searle, E.R.Squibb, Bayer and Dey Laboratories, as well as Procter & Gamble. He holds a Bachelor of Science degree in Chemistry from Illinois Benedictine College, a Master of Science in Organic Chemistry from Wichita State University, and a Ph.D. in Organic Chemistry from the University of Missouri.

VasoGenix Pharmaceuticals, Inc.
Jeffrey L. Southard, Co-Founder, Vice President Drug Development
Tuesday, April 11, 2006
4:45 p.m.
McCormick Place South, Level 3 Exhibit Hall A – Room D

Mr. Southard has spent his entire 20 year R&D career in the pharmaceutical industry in positions that encompass all aspects of the pharmaceutical drug development process from product discovery to market approval. Mr. Southard has authored numerous publications and holds several patents related to medical device and drug formulation development. Prior to finding and licensing the technology that would ultimately launch VasoGenix, Mr. Southard held positions at Aventis, Pharmaceutical Research Associates, PPD Pharmaco, Telectronics Rhythm Management Systems and Atrix Laboratories (QLT USA). He received his B.S. Degree in Biology from Colorado State University and trained as a U.S. Army Medic specializing in flight, ER and trauma medicine.

All full and session-only conference registrants are welcome in the Business Forum. There is no fee to enter, network or attend company presentations.

Click Here to view the BIO 2006 Agenda.